Decode
Market dynamics.
Funded by AP-HP, the Paris Saclay Cancer Cluster and Bpifrance, BOPtech is the Chair's technology and scientific platform, based directly inside the operating room of the Hepato-Biliary Center. It connects MedTech, Biotech and academic research to accelerate, as close to the field as possible, innovation in image-guided surgery, endoscopy and hepato-bilio-pancreatic oncology.

Every function of the human body is reproduced by a technical module, to keep an explanted liver in near-physiological conditions - the principle behind InMachina.

Supported by the PSCC, InMachina opens a new path in translational medicine: keeping cancerous human livers (HCC, CCA, metastases) in near-physiological conditions for 7 to 14 days.
This unique model lets biotech, medtech and healthcare companies test their innovations in an ultra-realistic ex vivo environment before any move into the clinic - to de-risk, validate and accelerate the development of new therapies.
Thanks to Bpifrance's support, the CHB's Hybrid Room opens its doors to MedTech companies to test, validate and evolve their innovations under real conditions: image-guided surgery, endoscopy, ultrasound or interventional radiology.
This platform is equipped with the Philips Azurion 7, a latest-generation system boosted by artificial intelligence - a unique opportunity to accelerate clinical development in a hospital environment of excellence.
Innovating is good. Innovating with impact is better: draw on our field expertise to turn your ideas into clinical success.
Market dynamics.
The clinical acceptability of your innovations.
The usability of your healthcare innovations.
At the CHB, a reference center for liver surgery, this unique volume of explanted human livers offers privileged access to a living preclinical model, usable for several hours - a rare opportunity to test devices or therapies before the next stage.